• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症患者恶病质护理的现状和未来预期。

Current and anticipated future state of cachexia care in patients with cancer.

机构信息

Riverside Health System, Newport News, VA  23601, USA.

MHA, Oncology, Pharmacy & Respiratory Services, Baptist Health, Little Rock , AR 72205, USA.

出版信息

Future Oncol. 2024;20(25):1825-1836. doi: 10.1080/14796694.2024.2341576. Epub 2024 Jun 12.

DOI:10.1080/14796694.2024.2341576
PMID:38864490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11486164/
Abstract

We assessed care in cancer patients with cachexia across leading health systems (LHSs). Qualitative interviews and quantitative surveys were conducted with LHSs executives and frontline health care personnel, representing 46 total respondents and 42 unique LHSs and including oncology service line leaders, supportive care services, dietitians and surgical oncologists. Cachexia was not considered a top priority, and formal diagnoses were rare. Participants highlighted the importance of addressing barriers to increase clinical trial enrollment and support frontline health care personnel and patients in early detection of cachexia. Cachexia prioritization needs to be elevated across LHSs executives to obtain capital and strategic imperatives to advance related care.

摘要

我们评估了在主要医疗系统（LHS）中患有恶病质的癌症患者的护理情况。对 LHS 高管和一线医护人员进行了定性访谈和定量调查，共有 46 位受访者和 42 个独特的 LHS，包括肿瘤学服务线领导者、支持性护理服务、营养师和外科肿瘤学家。恶病质并未被视为首要问题，且正式诊断较为罕见。参与者强调了克服障碍以增加临床试验参与度、为一线医护人员和患者提供支持以早期发现恶病质的重要性。LHS 高管需提升对恶病质的重视程度，以获取资本和战略动力，推进相关护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/d7d2822d62c7/IFON_A_2341576_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/701779309ee8/IFON_A_2341576_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/0070d4b7d05e/IFON_A_2341576_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/df3d1e66ad66/IFON_A_2341576_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/35e54f64c978/IFON_A_2341576_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/4c2b762a6ba3/IFON_A_2341576_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/186d418e9ed7/IFON_A_2341576_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/d7d2822d62c7/IFON_A_2341576_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/701779309ee8/IFON_A_2341576_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/0070d4b7d05e/IFON_A_2341576_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/df3d1e66ad66/IFON_A_2341576_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/35e54f64c978/IFON_A_2341576_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/4c2b762a6ba3/IFON_A_2341576_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/186d418e9ed7/IFON_A_2341576_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ad/11486164/d7d2822d62c7/IFON_A_2341576_F0007_C.jpg

相似文献

1
Current and anticipated future state of cachexia care in patients with cancer.癌症患者恶病质护理的现状和未来预期。
Future Oncol. 2024;20(25):1825-1836. doi: 10.1080/14796694.2024.2341576. Epub 2024 Jun 12.
2
Unidentified cachexia patients in the oncologic setting: Cachexia UFOs do exist.肿瘤学环境中不明原因恶病质患者：恶病质 UFO 确实存在。
Nutrition. 2019 Jul-Aug;63-64:200-204. doi: 10.1016/j.nut.2019.02.015. Epub 2019 Feb 27.
3
What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study.患者和肿瘤学家如何看待癌症相关性厌食-恶病质的评估和管理？Quasar_SEOM 研究。
Clin Transl Oncol. 2023 Dec;25(12):3479-3491. doi: 10.1007/s12094-023-03212-7. Epub 2023 Jun 8.
4
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps.癌症恶病质患者的识别与管理：评估医疗保健提供者的知识和实践差距。
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2683-2696. doi: 10.1002/jcsm.13105. Epub 2022 Oct 11.
5
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.满足癌症恶病质患者未满足的需求：多利益相关方研讨会的建议
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1418-1425. doi: 10.1002/jcsm.12910. Epub 2022 Feb 26.
6
Bridging gaps in cancer cachexia Care: Current insights and future perspectives.弥合癌症恶病质护理中的差距：当前的见解和未来的展望。
Cancer Treat Rev. 2024 Apr;125:102717. doi: 10.1016/j.ctrv.2024.102717. Epub 2024 Mar 13.
7
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force.癌症患者营养不良和恶病质的早期识别：欧洲肿瘤内科学会工作组立场文件。
Ann Oncol. 2014 Aug;25(8):1492-9. doi: 10.1093/annonc/mdu085. Epub 2014 Feb 25.
8
Cancer cachexia: a multifactoral disease that needs a multimodal approach.癌症恶病质：一种多因素疾病，需要多模式治疗方法。
Curr Opin Gastroenterol. 2020 Mar;36(2):141-146. doi: 10.1097/MOG.0000000000000603.
9
Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action.克服癌症恶病质及时识别与治疗的障碍：分享癌症护理特别工作组立场文件及行动呼吁中的进展
Crit Rev Oncol Hematol. 2023 May;185:103965. doi: 10.1016/j.critrevonc.2023.103965. Epub 2023 Mar 15.
10
Cancer cachexia: Diagnosis, assessment, and treatment.癌症恶病质：诊断、评估与治疗。
Crit Rev Oncol Hematol. 2018 Jul;127:91-104. doi: 10.1016/j.critrevonc.2018.05.006. Epub 2018 May 31.

本文引用的文献

1
The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials.安那莫林（ONO-7643）对癌症患者恶病质的影响：随机对照试验的系统评价和荟萃分析。
J Oncol Pharm Pract. 2023 Oct;29(7):1725-1735. doi: 10.1177/10781552231189864. Epub 2023 Aug 1.
2
The Latest Treatments for Cancer Cachexia: An Overview.癌症恶病质的最新治疗方法：概述。
Anticancer Res. 2023 Feb;43(2):511-521. doi: 10.21873/anticanres.16188.
3
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps.
癌症恶病质患者的识别与管理：评估医疗保健提供者的知识和实践差距。
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2683-2696. doi: 10.1002/jcsm.13105. Epub 2022 Oct 11.
4
Nutritional Interventions to Improve Cachexia Outcomes in Cancer-A Systematic Review.营养干预改善癌症恶病质结局的系统评价。
Medicina (Kaunas). 2022 Jul 21;58(7):966. doi: 10.3390/medicina58070966.
5
Accelerating Virtual Health Implementation Following the COVID-19 Pandemic: Questionnaire Study.COVID-19大流行后加速虚拟健康的实施：问卷调查研究
JMIR Form Res. 2022 May 16;6(5):e32819. doi: 10.2196/32819.
6
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.满足癌症恶病质患者未满足的需求：多利益相关方研讨会的建议
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1418-1425. doi: 10.1002/jcsm.12910. Epub 2022 Feb 26.
7
Development and progression of cancer cachexia: Perspectives from bench to bedside.癌症恶病质的发生与进展：从 bench 到 bedside 的视角
Sports Med Health Sci. 2020 Dec;2(4):177-185. doi: 10.1016/j.smhs.2020.10.003. Epub 2020 Dec 3.
8
The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review.根据不同癌症类型和治疗环境，肿瘤患者营养不良/恶病质/肌肉减少症的范围：叙述性综述。
Nutrients. 2021 Jun 9;13(6):1980. doi: 10.3390/nu13061980.
9
Evaluation of a Multidisciplinary Cachexia and Nutrition Support Service- The Patient and Carers Perspective.多学科恶病质与营养支持服务评估——患者及护理人员的视角
J Patient Exp. 2021 Jan 16;8:2374373520981476. doi: 10.1177/2374373520981476. eCollection 2021.
10
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines.成人癌症恶病质：ESMO 临床实践指南。
ESMO Open. 2021 Jun;6(3):100092. doi: 10.1016/j.esmoop.2021.100092.